Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia: a comment
- PMID: 30963445
- DOI: 10.1007/s11096-019-00822-6
Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia: a comment
Comment on
-
Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia in Saudi Arabia.Int J Clin Pharm. 2018 Oct;40(5):1051-1058. doi: 10.1007/s11096-018-0713-x. Epub 2018 Aug 16. Int J Clin Pharm. 2018. PMID: 30117080
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
